Showing results (11-20 of 142) with videos related to
Sort By:
Pageof 15
Medicine|January 14, 2022
Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case reportYuichiro Iwamoto, Fuminori Tatsumi, Kenji Kohara, et al.Molecular and Cellular Endocrinology|November 24, 2011
Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survivalKoji Nakashima, Masashi Shimoda, Sumiko Hamamoto, et al.Journal of Diabetes|October 19, 2016
Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistanceHideaki Kaneto, Atsushi Obata, Tomohiko Kimura, et al.Biomedicines|April 23, 2022
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes MellitusHideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, et al.Journal of Diabetes|July 31, 2015
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better"Hideaki Kaneto, Taka-Aki Matsuoka, Tomohiko Kimura, et al.Current Medicinal Chemistry|July 1, 2016
Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as well as Incretin-Related DrugsHideaki Kaneto, Atsushi Obata, Masashi Shimoda, et al.BMC Endocrine Disorders|August 13, 2021
Concurrence of overt Cushing's syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case reportYoshiro Fushimi, Fuminori Tatsumi, Junpei Sanada, et al.Medicine|March 8, 2024
A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitorsYuichiro Iwamoto, Fuminori Tatsumi, Mana Ohnishi, et al.American Journal of Physiology. Endocrinology and Metabolism|November 19, 2009
Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonistYukiko Kanda, Masashi Shimoda, Sumiko Hamamoto, et al.International Journal of Molecular Sciences|December 16, 2020
Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin SignalingHideaki Kaneto, Atsushi Obata, Tomohiko Kimura, et al.Pageof 15